← Open Payments lookup

SARA CURTIS: Open Payments

NPI 1407251424 · SALISBURY, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,580 in 67 payments from 14 companies in 2025. Trend: 2023 $1,683 · 2024 $1,795 · 2025 $1,580

Food & beverage: $1,580
CompanyPaymentsAmount
Novartis Pharmaceuticals Corporation23$333
Amgen Inc.7$197
SCPHARMACEUTICALS INC.5$182
E.R. Squibb & Sons, L.L.C.3$172
Boehringer Ingelheim Pharmaceuticals, Inc.6$157
Bayer Healthcare Pharmaceuticals Inc.5$117
PFIZER INC.6$113
Medtronic, Inc.1$110
Merck Sharp & Dohme LLC3$51
Actelion Pharmaceuticals US, Inc.2$40

Products named: LEQVIO, REPATHA, FUROSCIX, JARDIANCE, Kerendia, AURORA EV-ICD MRI SURESCAN, ELIQUIS, CAMZYOS.

Industry payments across MD — which companies pay providers there.